Cibisatamab
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1855925-27-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1189845-01 0.02 mg (E-Coli)
Recombinant Brugia malayi F-box/SPRY domain-containing protein 1 (Bm1_56115)
Ask
View Details 
MBS1189845-02 0.02 mg (Yeast)
Recombinant Brugia malayi F-box/SPRY domain-containing protein 1 (Bm1_56115)
Ask
View Details MBS1189845-03 0.1 mg (E-Coli)
Recombinant Brugia malayi F-box/SPRY domain-containing protein 1 (Bm1_56115)
Ask
View Details 
MBS1189845-04 0.1 mg (Yeast)
Recombinant Brugia malayi F-box/SPRY domain-containing protein 1 (Bm1_56115)
Ask
View Details MBS1189845-05 0.02 mg (Baculovirus)
Recombinant Brugia malayi F-box/SPRY domain-containing protein 1 (Bm1_56115)
Ask
View Details